Back to search
FDAFDA · Food and drugs·Recall number D-0138-2026

Espumil, Lipophilic foam base, 500 ml, 24G15-T02-115604

Published November 5, 2025 · Recall initiated: September 12, 2025

Summary

FDA records drug Class III recall D-0138-2026, published November 5, 2025 and initiated September 12, 2025. Recalling firm: Letco Medical LLC; Status: Ongoing; Reported quantity: 173 500 ml bottles; Lot: Batch # 24G15-T02-115604, exp. 11/30/2026. Class III means the product is not likely to cause adverse health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Not Elsewhere Classified

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Letco Medical LLC
Distributor
Product was distributed to: Letco Medical, LLC 1316 Commerce Drive Decatur, AL 35601 Product was further distributed to 44 compounding pharmacies and 2 distributors.
Lot
Batch # 24G15-T02-115604, exp. 11/30/2026
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Espumil, Lipophilic foam base, 500 ml, 24G15-T02-115604 recalled?

Yes. FDA published recall D-0138-2026 on November 5, 2025. Reported hazard: Labeling: Not Elsewhere Classified

What should I do if I have this product?

Voluntary: Firm initiated · Letter